Guan’s research discovered a significant association between mutations in NFE2L2, which encodes the transcription factor Nrf2, and increased resistance to radiotherapy in oral cancer patients undergoing surgery and adjuvant chemo/radiotherapy. Here, NFE2L2 is linked to lip and oral cavity carcinoma.